In SOD1 models, GLT-1 levels decrease as disease progresses (Bruijn et al., 1997) and this finding is consistent in human ALS spinal cord and brain (Rothstein et al., 1995). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.